Sangamo Therapeutics on the New Frontiers of Genomic Medicine
Sangamo Therapeutics is working to translate groundbreaking science into genomic cures. Learn more on Health Professional Radio.
3308 articles
Sangamo Therapeutics is working to translate groundbreaking science into genomic cures. Learn more on Health Professional Radio.
Allison McMullen, PhD, Scientific Partner for Molecular Diagnostics at Roche Diagnostics discusses a survey that shows that many Americans are confused ...
Arik Eisenkraft, MD., VP Clinical & Regulation at Biobeat, a digital tech company developing its proprietary data collection tools for remote patient mo...
David Harrell, Chairman and CEO of TranspareRX, the leading healthcare technology company bringing transparency to prescription drug pricing discusses C...
Whether healthcare workers are on the front-line treating patients or working behind the scenes, the ability to successfully navigate change, rise above...
Therapy, in its many forms, has long been recognized as an essential tool in managing mental health, improving relationships, navigating life transition...
Jim Geraghty discusses rare diseases and his book "Inside The Orphan Drug Revolution: The Promise of Patient-Centered Biotechnology.
Bernadette Hee, MD, a pulmonary/critical care medicine physician shares her experience working through COVID and how she found an outlet from the stress...
Ira Spector, PhD, co-founder and CEO of SFA Therapeutics, discusses the company's development of a novel platform to treat chronic, inflammation-mediate...
Graft-versus-host disease, also known as GVHD, is a life-threatening condition that can occur after an allogeneic stem cell transplant, or the transfer ...